Will Authorised Biologics Deter Biosimilars Utilising JFTC's Expertise in Drug Pricing

16-06-2022

In the US, the impact of authorised biologics on biosimilars is post-regulated by the competition authorities, while in Europe, pharmaceutical regulatory authorities consider competition impacts in addition to post-regulation by the competition authorities. 


LSIPR